§ 1701.
(3)
Demand reduction
The term “demand reduction” means any activity conducted by a National Drug Control Program agency, other than an enforcement activity, that is intended to reduce or prevent the use of drugs or support, expand, or provide treatment and recovery efforts, including—
(A)
education about the dangers of illicit drug use;
(B)
services, programs, or strategies to prevent substance use disorder, including evidence-based education campaigns, community-based prevention programs, collection and disposal of unused prescription drugs, and services to at-risk populations to prevent or delay initial use of an illicit drug;
(C)
substance use disorder treatment;
(D)
support for long-term recovery from substance use disorders;
(E)
drug-free workplace programs;
(F)
drug testing, including the testing of employees;
(G)
interventions for illicit drug use and dependence;
(H)
expanding availability of access to health care services for the treatment of substance use disorders;
(I)
international drug control coordination and cooperation with respect to activities described in this paragraph;
(J)
pre- and post-arrest criminal justice interventions such as diversion programs, drug courts, and the provision of evidence-based treatment to individuals with substance use disorders who are arrested or under some form of criminal justice supervision, including medication assisted treatment;
(K)
other coordinated and joint initiatives among Federal, State, local, and Tribal agencies to promote comprehensive drug control strategies designed to reduce the demand for, and the availability of, illegal drugs;
(L)
international illicit drug use education, prevention, treatment, recovery, research, rehabilitation activities, and interventions for illicit drug use and dependence; and
(M)
research related to illicit drug use and any of the activities described in this paragraph.
(15)
State, local, and Tribal affairs
The term “State, local, and Tribal affairs” means domestic activities conducted by a National Drug Control Program agency that are intended to reduce the availability and use of illegal drugs, including—
(A)
coordination and enhancement of Federal, State, local, and Tribal law enforcement drug control efforts;
(B)
coordination and enhancement of efforts among National Drug Control Program agencies and State, local, and Tribal demand reduction and supply reduction agencies;
(C)
coordination and enhancement of Federal, State, local, and Tribal law enforcement initiatives to gather, analyze, and disseminate information and law enforcement intelligence relating to drug control among domestic law enforcement agencies; and
(D)
other coordinated and joint initiatives among Federal, State, local, and Tribal agencies to promote comprehensive drug control strategies designed to reduce the demand for, and the availability of, illegal drugs.
(17)
Supply reduction
The term “supply reduction” means any activity or program conducted by a National Drug Control Program agency that is intended to reduce the availability or use of illegal drugs in the United States or abroad, including—
(A)
law enforcement outside the United States;
(B)
domestic law enforcement;
(C)
source country programs, including economic development programs primarily intended to reduce the production or trafficking of illicit drugs;
(D)
activities to control international trafficking in, and availability of, illegal drugs, including—
(i)
accurate assessment and monitoring of international drug production and interdiction programs and policies; and
(ii)
coordination and promotion of compliance with international treaties relating to the production, transportation, or interdiction of illegal drugs;
(E)
activities to conduct and promote international law enforcement programs and policies to reduce the supply of drugs;
(F)
activities to facilitate and enhance the sharing of domestic and foreign intelligence information among National Drug Control Program agencies, relating to the production and trafficking of drugs in the United States and in foreign countries;
(G)
activities to prevent the diversion of drugs for their illicit use; and
(H)
research related to any of the activities described in this paragraph.
([Pub. L. 105–277, div. C, title VII], §§ 702, 715, Oct. 21, 1998, [112 Stat. 2681–670], 2681–693; [Pub. L. 109–469, title I, § 101], title VI, § 602, Dec. 29, 2006, [120 Stat. 3503], 3533; [Pub. L. 115–271, title VIII], §§ 8202(a), (b)(2), 8216, Oct. 24, 2018, [132 Stat. 4110], 4117; [Pub. L. 116–74, § 2(a)(1)], (3), Nov. 27, 2019, [133 Stat. 1155].)